Evolent Health, Inc.
A healthcare services company that helps health plans, providers, and hospitals manage complex, high-cost conditions like cancer, heart disease, and musculoskeletal care. It uses its Identifi technology platform and clinical programs to help organizations move from simply billing per visit to "value-based care" that rewards better outcomes. Evolent was founded in 2011 as a joint venture between UPMC and The Advisory Board Company, based in Arlington, Virginia. Its name blends "evolution" and "benevolent," chosen to signal a kinder, transforming approach to healthcare.
Sold 8.29M
Sold 12.89M
Sold 5.90M
Sold 5.69M
Granted 2.22M · Bought 35.0K · Sold 2.24M
Granted 2.90M · Bought 70.0K · Sold 1.80M
Granted 437.8K · Bought 11.0K · Sold 46.2K
Granted 510.4K · Sold 63.1K
Granted 21.9K · Sold 55.2K
Granted 536.0K · Sold 212.5K
Bought 2.0K
Granted 160.3K · Sold 439.0K
Granted 166.8K · Sold 102.6K
Granted 89.3K · Sold 16.8K
Granted 112.7K · Bought 11.0K
Granted 75.8K · Bought 30.0K
Granted 92.1K · Bought 10.5K
Granted 69.9K · Bought 30.0K
Granted 9.7K · Sold 18.4K
Granted 93.0K · Bought 2.0K
Granted 58.5K · Bought 35.0K
Granted 172.9K · Sold 92.9K
Granted 71.9K · Bought 5.4K
Granted 75.2K
Granted 102.4K · Sold 18.9K
Granted 74.0K · Bought 2.7K · Sold 12.0K
Granted 61.2K
Granted 95.5K
Granted 64.2K
Granted 63.1K
Granted 47.9K
Granted 59.0K · Sold 12.6K
Granted 70.7K · Sold 13.1K
Granted 36.0K · Bought 7.2K · Sold 4.0K
Granted 15.4K
Granted 54.3K · Sold 109.3K
Granted 14.0K
Granted 587.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Upmc10% owner · 5 transactions | — | 6.43Mas of May 2017 | — | — | 8.29M |
| Bonderman David +2 co-filersReporting owner · 12 transactions | — | 4.40Mas of Jun 2017 | — | — | 12.89M |
| Unitedhealth Group IncReporting owner · 3 transactions | — | 4.13Mas of Jun 2018 | — | — | 5.90M |
| Advisory Board Co10% owner · 8 transactions | — | 4.13Mas of May 2017 | — | — | 5.69M |
| Williams Frank JDirector · 112 transactions | — | 885.9Kas of Jun 2023 | 2.22M | 35.0K | 2.24M |
| Blackley SethChief Executive Officer, Director · 88 transactions | — | 837.0K | 2.90M | 70.0K | 1.80M |
| McCarthy Daniel JosephPRESIDENT · 30 transactions | — | 423.0K | 437.8K | 11.0K | 46.2K |
| Johnson John PaulChief Financial Officer · 24 transactions | — | 309.2Kas of Jul 2025 | 510.4K | — | 63.1K |
| Pomeroy ChadChief Technology Officer · 2 transactions | — | 286.4Kas of Sep 2016 | 21.9K | — | 55.2K |
| Weinberg JonathanGeneral Counsel · 57 transactions | — | 244.5K | 536.0K | — | 212.5K |
| Piefer GaryChief Medical Officer · 1 transaction | — | 206.3Kas of Jun 2015 | — | 2.0K | — |
| Peterson Thomas IIIChief Operating Officer · 25 transactions | — | 137.9Kas of Sep 2018 | 160.3K | — | 439.0K |
| Tutewohl SteveChief Operating Officer · 39 transactions | — | 136.3Kas of Jul 2023 | 166.8K | — | 102.6K |
| Rafferty Emily AnnChief Operating Officer · 9 transactions | — | 132.6Kas of Mar 2025 | 89.3K | — | 16.8K |
| Grua Peter JDirector · 9 transactions | — | 123.7K | 112.7K | 11.0K | — |
| Jelinek Richard MDirector · 6 transactions | — | 107.5K | 75.8K | 30.0K | — |
| Keck KimDirector · 8 transactions | — | 102.6K | 92.1K | 10.5K | — |
| Springstubb Brendan BDirector · 6 transactions | — | 99.9K | 69.9K | 30.0K | — |
| Thornton DaveChief Talent Officer · 2 transactions | — | 95.5Kas of Sep 2016 | 9.7K | — | 18.4K |
| Barbarosh Craig A.Director · 8 transactions | — | 95.0K | 93.0K | 2.0K | — |
| D'Amato MichaelDirector · 9 transactions | — | 93.5Kas of Jun 2021 | 58.5K | 35.0K | — |
| McGrane NicholasChief Financial Officer · 23 transactions | — | 84.1Kas of Mar 2019 | 172.9K | — | 92.9K |
| Glass Russell MonroeDirector · 5 transactions | — | 83.4K | 71.9K | 5.4K | — |
| Ajayi ToyinDirector · 4 transactions | — | 75.2K | 75.2K | — | — |
| Scott CherylDirector · 17 transactions | — | 73.5Kas of Jun 2025 | 102.4K | — | 18.9K |
| Holder DianeDirector · 11 transactions | — | 70.6Kas of Mar 2025 | 74.0K | 2.7K | 12.0K |
| Farner DavidDirector · 7 transactions | — | 67.1Kas of Jun 2022 | 61.2K | — | — |
| Shams AammaadChief Accounting Officer · 19 transactions | — | 66.8K | 95.5K | — | — |
| Smith Jill D.Director · 2 transactions | — | 64.2K | 64.2K | — | — |
| Guertin Shawn MDirector · 2 transactions | — | 63.1K | 63.1K | — | — |
| Felt Bruce C. Jr.Director · 5 transactions | — | 53.7Kas of Jun 2020 | 47.9K | — | — |
| Stone LydiaChief Accounting Officer · 20 transactions | — | 48.9Kas of Mar 2020 | 59.0K | — | 12.6K |
| Duffy Mary BridgetDirector · 10 transactions | — | 48.0Kas of Jun 2024 | 70.7K | — | 13.1K |
| Samet Kenneth ADirector · 7 transactions | — | 39.2Kas of Aug 2019 | 36.0K | 7.2K | 4.0K |
| Payson NormanDirector · 3 transactions | — | 21.3Kas of Jun 2018 | 15.4K | — | — |
| Wigginton SteveCEO, Valence Health · 22 transactions | — | 18.4Kas of Aug 2017 | 54.3K | — | 109.3K |
| Sotunde TundeDirector · 3 transactions | — | 14.0Kas of Jun 2023 | 14.0K | — | — |
| Ramos MarioChief Financial Officer · 1 transaction | — | 0 | 587.5K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -37.78M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.